Market Cap 181.54M
Revenue (ttm) 1.08B
Net Income (ttm) 95.40M
EPS (ttm) N/A
PE Ratio 1.12
Forward PE 1.80
Profit Margin 8.83%
Debt to Equity Ratio -2.12
Volume 1,761,336
Avg Vol 1,961,796
Day's Range N/A - N/A
Shares Out 59.33M
Stochastic %K 55%
Beta 1.09
Analysts Hold
Price Target $4.00

Company Profile

Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headqu...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 862 401 0000
Address:
300 Kimball Drive, Suite 300, Parsippany, United States
TradingThyme
TradingThyme May. 22 at 8:28 PM
$EMBC Travis Steed from Bank of America dropped his rating on this from 11 to 3. the stock has already outperformed his rating by 10%. Hedge funds have purchased just over 1 million shares since the drop in price. Many circumstances like these they ”reevaluateβ€œ after making their initial 30% to further drive their profits. They are in it to make money. Let that sink in. Always do your own research before investing your money for or against.
0 Β· Reply
LordWorld
LordWorld May. 22 at 8:05 PM
$EMBC This is a major player!!! Closed very strongly.🟩
0 Β· Reply
Gunnar1
Gunnar1 May. 22 at 5:47 PM
$EMBC I like the daily chart and my avg after loading over the last days. Still very oversold and with a massive gap. MACD is slowly curling up and price went above EMA5. We'll see...
0 Β· Reply
DDtrader444
DDtrader444 May. 22 at 3:42 PM
$EMBC lol shorts have most the available float(after institutional/insider ownership) to cover. That sounds like a fun ride up for them when news hits them like a Mac truckπŸ˜‚πŸ€¦β€β™‚οΈ
1 Β· Reply
OrangeJoolius
OrangeJoolius May. 22 at 2:35 PM
$EMBC Called it. Down she goes.
1 Β· Reply
DDtrader444
DDtrader444 May. 22 at 1:45 PM
$EMBC ↗️↗️↗️
0 Β· Reply
Masterson83
Masterson83 May. 21 at 11:22 PM
$EMBC Just a slight miss on earnings and this dropped from $8…hmmm. Is reversal really triggered?
1 Β· Reply
LordWorld
LordWorld May. 21 at 8:20 PM
$EMBC 10,000 pharmacies https://halifax.citynews.ca/2026/05/20/generic-semaglutide-to-hit-canadian-pharmacies-this-week-at-a-fraction-of-the-cost-of-ozempic/
0 Β· Reply
LordWorld
LordWorld May. 21 at 8:06 PM
$EMBC 🟩🟩🟩🟩🟩🟩🟩🟩 🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩 🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩
0 Β· Reply
ALag77
ALag77 May. 21 at 7:36 PM
$EMBC Another easy, successful 16 pennies. Good luck longs....I hope this goes pops hard for you all 😁
0 Β· Reply
Latest News on EMBC
Embecta price target lowered to $3 from $11 at BofA

2026-05-18T12:09:46.000Z - 4 days ago

Embecta price target lowered to $3 from $11 at BofA


Embecta price target lowered to $5 from $12 at Mizuho

2026-05-07T06:57:11.000Z - 15 days ago

Embecta price target lowered to $5 from $12 at Mizuho


Embecta Earnings Call Transcript: Q2 2026

May 5, 2026, 8:00 AM EDT - 17 days ago

Embecta Earnings Call Transcript: Q2 2026


Embecta Earnings release: Q2 2026

May 5, 2026, 8:00 AM EDT - 17 days ago

Embecta Earnings release: Q2 2026


Embecta Slides: Q2 2026

May 5, 2026, 8:00 AM EDT - 17 days ago

Embecta Slides: Q2 2026


Embecta Quarterly report: Q2 2026

May 5, 2026, 8:00 AM EDT - 17 days ago

Embecta Quarterly report: Q2 2026


Embecta reports Q2 adjusted EPS 27c, consensus 42c

2026-05-05T10:48:58.000Z - 17 days ago

Embecta reports Q2 adjusted EPS 27c, consensus 42c


embecta Announces Quarterly Cash Dividend

May 5, 2026, 6:30 AM EDT - 17 days ago

embecta Announces Quarterly Cash Dividend


Embecta management to meet virtually with BTIG

2026-04-29T17:50:52.000Z - 23 days ago

Embecta management to meet virtually with BTIG


embecta to Report Fiscal Second Quarter Financial Results

Apr 21, 2026, 5:00 PM EDT - 4 weeks ago

embecta to Report Fiscal Second Quarter Financial Results


Embecta price target lowered to $12 from $14 at Mizuho

2026-04-13T14:41:50.000Z - 5 weeks ago

Embecta price target lowered to $12 from $14 at Mizuho


Embecta price target lowered to $22 from $25 at BTIG

2026-04-13T11:55:26.000Z - 5 weeks ago

Embecta price target lowered to $22 from $25 at BTIG


Embecta acquiring Owen Mumford Holdings

2026-03-19T10:46:35.000Z - 2 months ago

Embecta acquiring Owen Mumford Holdings


Embecta elects CEO Devdatt Kurdikar as chairman

2026-02-11T21:21:38.000Z - 3 months ago

Embecta elects CEO Devdatt Kurdikar as chairman


Embecta Earnings Call Transcript: Q1 2026

Feb 5, 2026, 8:00 AM EST - 3 months ago

Embecta Earnings Call Transcript: Q1 2026


Embecta Quarterly report: Q1 2026

Feb 5, 2026, 8:00 AM EST - 3 months ago

Embecta Quarterly report: Q1 2026


Embecta Earnings release: Q1 2026

Feb 5, 2026, 8:00 AM EST - 3 months ago

Embecta Earnings release: Q1 2026


Embecta Slides: Q1 2026

Feb 5, 2026, 8:00 AM EST - 3 months ago

Embecta Slides: Q1 2026


Embecta reports Q1 adjusted EPS 71c, consensus 67c

2026-02-05T11:42:06.000Z - 3 months ago

Embecta reports Q1 adjusted EPS 71c, consensus 67c


Embecta Proxy statement: Proxy Filing

Jan 23, 2026, 7:00 AM EST - 4 months ago

Embecta Proxy statement: Proxy Filing


embecta to Report Fiscal First Quarter Financial Results

Jan 22, 2026, 5:00 PM EST - 4 months ago

embecta to Report Fiscal First Quarter Financial Results


Embecta Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 14, 2026, 5:15 PM EST - 4 months ago

Embecta Slides: 44th Annual J.P. Morgan Healthcare Conference


Embecta Proxy statement: Proxy Filing

Dec 18, 2025, 7:00 AM EST - 5 months ago

Embecta Proxy statement: Proxy Filing


Embecta Proxy statement: Proxy Filing

Dec 18, 2025, 7:00 AM EST - 5 months ago

Embecta Proxy statement: Proxy Filing


Embecta Earnings Call Transcript: Q4 2025

Nov 25, 2025, 8:00 AM EST - 6 months ago

Embecta Earnings Call Transcript: Q4 2025


Embecta Annual report: Q4 2025

Nov 25, 2025, 8:00 AM EST - 6 months ago

Embecta Annual report: Q4 2025


Embecta Earnings release: Q4 2025

Nov 25, 2025, 8:00 AM EST - 6 months ago

Embecta Earnings release: Q4 2025


Embecta Slides: Q4 2025

Nov 25, 2025, 8:00 AM EST - 6 months ago

Embecta Slides: Q4 2025


Embecta reports Q4 adjusted EPS 50c, consensus 46c

2025-11-25T11:35:52.000Z - 6 months ago

Embecta reports Q4 adjusted EPS 50c, consensus 46c


Embecta sees FY26 adjusted EPS $2.80-$3.00, consensus $2.95

2025-11-25T11:35:41.000Z - 6 months ago

Embecta sees FY26 adjusted EPS $2.80-$3.00, consensus $2.95


embecta announces changes to Board of Directors

Nov 17, 2025, 5:00 PM EST - 6 months ago

embecta announces changes to Board of Directors


Embecta management to meet with BTIG

2025-09-09T14:20:26.000Z - 9 months ago

Embecta management to meet with BTIG


embecta to Participate in Investor Events

Aug 26, 2025, 5:00 PM EDT - 9 months ago

embecta to Participate in Investor Events


Embecta price target lowered to $11 from $18 at BofA

2025-08-08T18:45:13.000Z - 10 months ago

Embecta price target lowered to $11 from $18 at BofA


Embecta Earnings Call Transcript: Q3 2025

Aug 8, 2025, 8:00 AM EDT - 10 months ago

Embecta Earnings Call Transcript: Q3 2025


Embecta Quarterly report: Q3 2025

Aug 8, 2025, 8:00 AM EDT - 10 months ago

Embecta Quarterly report: Q3 2025


Embecta Earnings release: Q3 2025

Aug 8, 2025, 8:00 AM EDT - 10 months ago

Embecta Earnings release: Q3 2025


Embecta Slides: Q3 2025

Aug 8, 2025, 8:00 AM EDT - 10 months ago

Embecta Slides: Q3 2025


Embecta reports Q3 adjusted EPS $1.12 vs. 74c last year

2025-08-08T10:35:32.000Z - 10 months ago

Embecta reports Q3 adjusted EPS $1.12 vs. 74c last year


embecta to Report Fiscal Third Quarter 2025 Financial Results

Jul 24, 2025, 5:00 PM EDT - 10 months ago

embecta to Report Fiscal Third Quarter 2025 Financial Results


Embecta price target lowered to $12 from $13 at Mizuho

2025-07-16T11:42:06.000Z - 11 months ago

Embecta price target lowered to $12 from $13 at Mizuho


Embecta price target lowered to $13 from $15 at Mizuho

2025-05-23T12:51:11.000Z - 1 year ago

Embecta price target lowered to $13 from $15 at Mizuho


Embecta Transcript: Investor Day 2025

May 22, 2025, 9:00 AM EDT - 1 year ago

Embecta Transcript: Investor Day 2025


Embecta Slides: FY 2025

May 22, 2025, 9:00 AM EDT - 1 year ago

Embecta Slides: FY 2025


Embecta Earnings Call Transcript: Q2 2025

May 9, 2025, 8:00 AM EDT - 1 year ago

Embecta Earnings Call Transcript: Q2 2025


Embecta Quarterly report: Q2 2025

May 9, 2025, 8:00 AM EDT - 1 year ago

Embecta Quarterly report: Q2 2025


Embecta Earnings release: Q2 2025

May 9, 2025, 8:00 AM EDT - 1 year ago

Embecta Earnings release: Q2 2025


Embecta Slides: Q2 2025

May 9, 2025, 8:00 AM EDT - 1 year ago

Embecta Slides: Q2 2025


Embecta to host Analyst and Investor Day on May 22, 2025

Apr 28, 2025, 7:30 AM EDT - 1 year ago

Embecta to host Analyst and Investor Day on May 22, 2025


Embecta Earnings Call Transcript: Q1 2025

Feb 6, 2025, 8:00 AM EST - 1 year ago

Embecta Earnings Call Transcript: Q1 2025


Embecta Quarterly report: Q1 2025

Feb 6, 2025, 8:00 AM EST - 1 year ago

Embecta Quarterly report: Q1 2025


Embecta Earnings release: Q1 2025

Feb 6, 2025, 8:00 AM EST - 1 year ago

Embecta Earnings release: Q1 2025


Embecta Slides: Q1 2025

Feb 6, 2025, 8:00 AM EST - 1 year ago

Embecta Slides: Q1 2025


embecta to Report Fiscal First Quarter 2025 Financial Results

Jan 23, 2025, 5:00 PM EST - 1 year ago

embecta to Report Fiscal First Quarter 2025 Financial Results


Embecta Slides: FY 2025

Jan 15, 2025, 10:30 AM EST - 1 year ago

Embecta Slides: FY 2025


Embecta Proxy statement: Proxy Filing

Dec 19, 2024, 7:00 AM EST - 1 year ago

Embecta Proxy statement: Proxy Filing


Embecta Proxy statement: Proxy Filing

Dec 19, 2024, 7:00 AM EST - 1 year ago

Embecta Proxy statement: Proxy Filing


Overlooked Stock: EMBC

Nov 27, 2024, 4:38 PM EST - 1 year ago

Overlooked Stock: EMBC


Embecta Earnings Call Transcript: Q4 2024

Nov 26, 2024, 8:00 AM EST - 1 year ago

Embecta Earnings Call Transcript: Q4 2024


Embecta Annual report: Q4 2024

Nov 26, 2024, 8:00 AM EST - 1 year ago

Embecta Annual report: Q4 2024


Embecta Earnings release: Q4 2024

Nov 26, 2024, 8:00 AM EST - 1 year ago

Embecta Earnings release: Q4 2024


Embecta Slides: Q4 2024

Nov 26, 2024, 8:00 AM EST - 1 year ago

Embecta Slides: Q4 2024


Embecta Earnings Call Transcript: Q3 2024

Aug 9, 2024, 8:00 AM EDT - 1 year ago

Embecta Earnings Call Transcript: Q3 2024


Embecta Quarterly report: Q3 2024

Aug 9, 2024, 8:00 AM EDT - 1 year ago

Embecta Quarterly report: Q3 2024


Embecta Earnings release: Q3 2024

Aug 9, 2024, 8:00 AM EDT - 1 year ago

Embecta Earnings release: Q3 2024


Embecta Slides: Q3 2024

Aug 9, 2024, 8:00 AM EDT - 1 year ago

Embecta Slides: Q3 2024


embecta to Report Fiscal Third Quarter 2024 Financial Results

Jul 18, 2024, 5:00 PM EDT - 2 years ago

embecta to Report Fiscal Third Quarter 2024 Financial Results


Embecta (EMBC) CEO on Diabetes Treatment Market

May 17, 2024, 4:30 PM EDT - 2 years ago

Embecta (EMBC) CEO on Diabetes Treatment Market


Embecta Transcript: BofA Securities 2024 Health Care Conference

May 16, 2024, 1:00 PM EDT - 2 years ago

Embecta Transcript: BofA Securities 2024 Health Care Conference


Embecta Earnings Call Transcript: Q2 2024

May 9, 2024, 8:00 AM EDT - 2 years ago

Embecta Earnings Call Transcript: Q2 2024


Embecta Quarterly report: Q2 2024

May 9, 2024, 8:00 AM EDT - 2 years ago

Embecta Quarterly report: Q2 2024


Embecta Earnings release: Q2 2024

May 9, 2024, 8:00 AM EDT - 2 years ago

Embecta Earnings release: Q2 2024


Embecta Slides: Q2 2024

May 9, 2024, 8:00 AM EDT - 2 years ago

Embecta Slides: Q2 2024


embecta to Report Fiscal Second Quarter 2024 Financial Results

Apr 23, 2024, 5:00 PM EDT - 2 years ago

embecta to Report Fiscal Second Quarter 2024 Financial Results


Embecta Earnings Call Transcript: Q1 2024

Feb 9, 2024, 8:00 AM EST - 2 years ago

Embecta Earnings Call Transcript: Q1 2024


Embecta Quarterly report: Q1 2024

Feb 9, 2024, 8:00 AM EST - 2 years ago

Embecta Quarterly report: Q1 2024


Embecta Earnings release: Q1 2024

Feb 9, 2024, 8:00 AM EST - 2 years ago

Embecta Earnings release: Q1 2024


Embecta Slides: Q1 2024

Feb 9, 2024, 8:00 AM EST - 2 years ago

Embecta Slides: Q1 2024


TradingThyme
TradingThyme May. 22 at 8:28 PM
$EMBC Travis Steed from Bank of America dropped his rating on this from 11 to 3. the stock has already outperformed his rating by 10%. Hedge funds have purchased just over 1 million shares since the drop in price. Many circumstances like these they ”reevaluateβ€œ after making their initial 30% to further drive their profits. They are in it to make money. Let that sink in. Always do your own research before investing your money for or against.
0 Β· Reply
LordWorld
LordWorld May. 22 at 8:05 PM
$EMBC This is a major player!!! Closed very strongly.🟩
0 Β· Reply
Gunnar1
Gunnar1 May. 22 at 5:47 PM
$EMBC I like the daily chart and my avg after loading over the last days. Still very oversold and with a massive gap. MACD is slowly curling up and price went above EMA5. We'll see...
0 Β· Reply
DDtrader444
DDtrader444 May. 22 at 3:42 PM
$EMBC lol shorts have most the available float(after institutional/insider ownership) to cover. That sounds like a fun ride up for them when news hits them like a Mac truckπŸ˜‚πŸ€¦β€β™‚οΈ
1 Β· Reply
OrangeJoolius
OrangeJoolius May. 22 at 2:35 PM
$EMBC Called it. Down she goes.
1 Β· Reply
DDtrader444
DDtrader444 May. 22 at 1:45 PM
$EMBC ↗️↗️↗️
0 Β· Reply
Masterson83
Masterson83 May. 21 at 11:22 PM
$EMBC Just a slight miss on earnings and this dropped from $8…hmmm. Is reversal really triggered?
1 Β· Reply
LordWorld
LordWorld May. 21 at 8:20 PM
$EMBC 10,000 pharmacies https://halifax.citynews.ca/2026/05/20/generic-semaglutide-to-hit-canadian-pharmacies-this-week-at-a-fraction-of-the-cost-of-ozempic/
0 Β· Reply
LordWorld
LordWorld May. 21 at 8:06 PM
$EMBC 🟩🟩🟩🟩🟩🟩🟩🟩 🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩 🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩🟩
0 Β· Reply
ALag77
ALag77 May. 21 at 7:36 PM
$EMBC Another easy, successful 16 pennies. Good luck longs....I hope this goes pops hard for you all 😁
0 Β· Reply
LordWorld
LordWorld May. 21 at 7:26 PM
$EMBC Tomorrow we will start publishing articles with analytical analysis and an extremely positive mood.
0 Β· Reply
Cheaslea76
Cheaslea76 May. 21 at 6:49 PM
0 Β· Reply
LordWorld
LordWorld May. 21 at 6:29 PM
$EMBC More than 90% of shares are in the hands of institutional investors, 1-1.5% are held by insiders.
0 Β· Reply
TradingThyme
TradingThyme May. 21 at 5:53 PM
$EMBC Reversal just triggered….
3 Β· Reply
LordWorld
LordWorld May. 21 at 5:30 PM
$EMBC 4,5 βœ… then 8 dollars
0 Β· Reply
acarsoy
acarsoy May. 21 at 5:20 PM
$EMBC up 8% already took one day πŸ€‘ stupid @yosiyosi
1 Β· Reply
LordWorld
LordWorld May. 21 at 5:15 PM
$EMBC https://www.reuters.com/legal/litigation/hims-offers-apotexs-generic-semaglutide-canada-after-novo-patent-expiry-2026-05-21/
1 Β· Reply
DavidDayTrade
DavidDayTrade May. 21 at 5:12 PM
$EMBC WAKE ME UP WHEN IT'S 7$
0 Β· Reply
yosiyosi
yosiyosi May. 21 at 4:38 PM
$EMBC sell sell sell
0 Β· Reply
OrangeJoolius
OrangeJoolius May. 21 at 4:27 PM
$EMBC No volume, this won't hold. We all know it.
2 Β· Reply
LordWorld
LordWorld May. 21 at 3:24 PM
$EMBC I wish you good luck in your expectations.
0 Β· Reply
Cutlass
Cutlass May. 21 at 3:15 PM
$EMBC All out for now - would revisit under 2.85
0 Β· Reply